Jnj key products

Johnson & Johnson (JNJ) has a diverse range of key products that contribute significantly to its revenue and market position. These key products include: 1. **Health Care Products**: JNJ is the world's leading maker of health care products, with a broad portfolio that includes medical devices, pharmaceuticals, and consumer health products. 2. **Medical Devices**: The company's medical devices segment includes products such as orthopedics, surgical devices, and electrophysiological products. 3. **Pharmaceuticals**: JNJ's pharmaceutical segment offers innovative medicines, including key products like Darzalex, Stelara, and Erleada. 4. **Consumer Health**: The company's consumer health segment includes well-known brands like Tylenol and Benadryl, which have grown recently due to the acquisition of the Pfizer consumer business in 2007. 5. **Other Key Products**: JNJ's portfolio also includes other key products, such as ABRYSV™ for Respiratory Syncytial Virus and the COVID-19 vaccine, which have been significant contributors to the company's revenue and market position. These key products are integral to JNJ's business strategy and financial performance, with the company's robust portfolio across multiple therapeutic areas ensuring a diversified revenue stream and mitigating risks associated with market fluctuations. The company's ability to innovate and bring new products to market, as well as its strong market presence, underpins its competitive edge in the healthcare industry.